Skip to main content
Clinical Trials/JPRN-UMIN000042166
JPRN-UMIN000042166
Completed
未知

A cluster randomized controlled trial on a procedure to ensure appropriate management of medications with strong teratogenicity. - A cluster randomized controlled trial on a procedure to ensure appropriate management of medications with strong teratogenicity.

Ministry of Health, Labou Safety Measures Section0 sites900 target enrollmentOctober 19, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Multiple myeloma
Sponsor
Ministry of Health, Labou Safety Measures Section
Enrollment
900
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2020
End Date
June 30, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ministry of Health, Labou Safety Measures Section

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Female patients with no possibility of pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials